YH Park

614 total citations
34 papers, 367 citations indexed

About

YH Park is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, YH Park has authored 34 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in YH Park's work include Advanced Breast Cancer Therapies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). YH Park is often cited by papers focused on Advanced Breast Cancer Therapies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). YH Park collaborates with scholars based in South Korea, United States and France. YH Park's co-authors include J-Y Jang, W H Kim, C-C Kim, W-S Min, Yoo‐Seok Yoon, Dongwook Kim, Y-H Im, Eunyoung Cho, Eunsoon Oh and Yong‐Jae Kim and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Investigative Ophthalmology & Visual Science.

In The Last Decade

YH Park

32 papers receiving 362 citations

Peers

YH Park

ONCOL

SURGE

HEMAT

PRM

SHOJIRO YANO Japan

Elizabeth Mroczek‐Musulman United States

Maxine L. Crook Australia

Haruhi Takagi Japan

Osama Roshdy Canada

Elvira Mustać Croatia

Keiko Kagami Japan

J.M. Tourani France

Tara Kendall United States

Emina Babarović Croatia

SHOJIRO YANO Japan

YH Park

77 ×0.5

ONCOL

84 ×0.8

SURGE

123 ×1.5

55 ×0.9

HEMAT

106 ×1.9

PRM

Citations per year, relative to YH Park YH Park (= 1×) peers SHOJIRO YANO

Countries citing papers authored by YH Park

Since Specialization

Citations

This map shows the geographic impact of YH Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by YH Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites YH Park more than expected).

Fields of papers citing papers by YH Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by YH Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by YH Park. The network helps show where YH Park may publish in the future.

Co-authorship network of co-authors of YH Park

This figure shows the co-authorship network connecting the top 25 collaborators of YH Park. A scholar is included among the top collaborators of YH Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with YH Park. YH Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, YH, et al.. (2019). A Systematic Review and Case Report on Mucinous Adenocarcinoma : Can Lymphatic Metastasis Decide the Fate of Mucinous Adenocarcinoma of Salivary Gland Origin?. 43(5). 179–187.

Loi, Sherene, Peter Schmid, Javier Cortés, et al.. (2019). Abstract P3-10-09: Relationship between tumor infiltrating lymphocytes (TILs) and response to pembrolizumab (Pembro)+chemotherapy (Chemo) as neoadjuvant treatment (NAT) for triple-negative breast cancer (TNBC): phase Ib KEYNOTE-173 trial. Cancer Research. 79(4_Supplement). P3–10. 5 indexed citations

Domchek, S. M., Sophie Postel‐Vinay, Y-J. Bang, et al.. (2018). Abstract PD6-11: An open-label, multitumor, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in germline BRCA -mutated (g BRCA m) HER2-negative metastatic breast cancer (MBC). Cancer Research. 78(4_Supplement). PD6–11. 41 indexed citations

Park, Jo, et al.. (2017). Lateral neck dissection affects the voice in thyroid cancer patients. The Journal of Laryngology & Otology. 131(10). 853–859. 6 indexed citations

Park, YH, Keun‐Hwa Jung, KS Lee, et al.. (2016). Abstract OT3-01-10: A prospective, open-label, single-arm, multi-center, phase II exploratory study to evaluate the efficacy and safety of poziotinib (NOV120101) in patients with HER2-positive metastatic breast cancer who have received at least two prior HER2-directed regimens. Cancer Research. 76(4_Supplement). OT3–1. 2 indexed citations

Park, YH, et al.. (2015). Activation of the pyrin inflammasome through the RhoA signaling pathway in FMF and HIDS. Pediatric Rheumatology. 13(S1). 2 indexed citations

Lee, Yung Seng, Jinwon Lee, JW Choi, et al.. (2015). The usefulness of modified national early warning score with the age level in critically ill medical patients. Intensive Care Medicine Experimental. 3(S1). 2 indexed citations

Park, YH, Ji Ho Yun, Hyun Jung Park, et al.. (2014). Determination of Feeder Cell‐Based Cellular Niches Supporting the Colonization and Maintenance of Spermatogonial Stem Cells from Prepubertal Domestic Cat Testes. Reproduction in Domestic Animals. 49(5). 705–710. 8 indexed citations

Kwon, Mi, Jung Yun Choi, Eunsoon Oh, et al.. (2012). Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. British Journal of Cancer. 106(5). 923–930. 56 indexed citations

10.

Park, YH, et al.. (2010). CASE REPORT: The CT and ¹⁸F‐FDG PET/CT appearance of primary renal malignant fibrous histiocytoma. Journal of Medical Imaging and Radiation Oncology. 54(4). 365–367. 14 indexed citations

11.

Lee, SJ, et al.. (2010). Abstract P6-13-04: Thymidylate Synthase (TS) and Thymidine Phosphorylase (TP) Expression as Predictive Markers of Capecitabine Mono-Chemotherapy for Patients with Anthracyclin-Taxane Pretreated Metastatic Breast Cancer (MBC). Cancer Research. 70(24_Supplement). P6–13. 2 indexed citations

12.

Park, YH, et al.. (2006). CAM in patients with gastrointestinal cancer in South Korea: a survey. Focus on Alternative and Complementary Therapies. 11(s1). 21–22. 1 indexed citations

13.

Park, YH, Ji‐Hyun Lee, Dongwook Kim, & Seung‐Hun Cho. (2005). Secondary Tongue Cancer in Patients with Chronic Graft-Versus-Host Disease(GVHD) after Bone Marrow Transplantation : Report of Two Cases. Korean Journal of Otorhinolaryngology-head and Neck Surgery. 48(8). 1047–1050.

14.

Kong, Hong Jin, et al.. (2005). Omnidirectional plane beam generation by a hollow tube prism. Review of Scientific Instruments. 76(2). 4 indexed citations

15.

Kim, Hyung Jun, W-S Min, K-S Eom, et al.. (2004). Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission. Bone Marrow Transplantation. 34(3). 215–220. 20 indexed citations

16.

Lee, Dong‐Gun, Su‐Mi Choi, YH Park, et al.. (2004). Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplantation. 34(6). 497–504. 47 indexed citations

17.

Kim, YJ, Dongwook Kim, Jae‐Yeon Hwang, et al.. (2003). Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatment. Bone Marrow Transplantation. 33(2). 237–242. 8 indexed citations

18.

Park, YH, et al.. (2002). The Results of Laser Photocoagulation in case of Branch Retinal Vein Occlusion With or Without Posterior Vitreous Detachment. Investigative Ophthalmology & Visual Science. 43(13). 500–500. 1 indexed citations

19.

Kim, W H, et al.. (2002). Establishment and characterisation of six human biliary tract cancer cell lines. British Journal of Cancer. 87(2). 187–193. 74 indexed citations

20.

Park, YH, et al.. (1991). Metabolism of the aldose reductase inhibitor ALO1567 in man.. British Journal of Clinical Pharmacology. 32(2). 221–227. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact